{
    "id": 18600,
    "fullName": "RIT1 Q79L",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "RIT1 Q79L lies within a GTP-binding region of the Rit1 protein (UniProt.org). Q79L results in decreased Rit1 GTPase activity, moderate increase of nucleotide exchange rate (PMID: 27226556), leads to increased phosphorylation of Mek, Erk, and Akt, induced neurite outgrowth, transformation of cultured cells, and tumorigenesis in mouse models (PMID: 15632082, PMID: 24469055).",
            "references": [
                {
                    "id": 16639,
                    "pubMedId": 27226556,
                    "title": "Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27226556"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 4469,
                    "pubMedId": 24469055,
                    "title": "Oncogenic RIT1 mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24469055"
                },
                {
                    "id": 18058,
                    "pubMedId": 15632082,
                    "title": "Rit contributes to nerve growth factor-induced neuronal differentiation via activation of B-Raf-extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15632082"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6016,
        "geneSymbol": "RIT1",
        "terms": [
            "RIT1",
            "NS8",
            "RIBB",
            "RIT",
            "ROC1"
        ]
    },
    "variant": "Q79L",
    "createDate": "02/24/2016",
    "updateDate": "03/08/2020",
    "referenceTranscriptCoordinates": {
        "id": 161621,
        "transcript": "NM_006912",
        "gDna": "chr1:g.155904732T>A",
        "cDna": "c.236A>T",
        "protein": "p.Q79L",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4748,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of Selumetinib (AZD-6244) and Pictilisib (GDC-0941) inhibited transformation of cells expressing RIT1 Q79L in culture, with increased efficacy compared to either agent alone (PMID: 24469055).",
            "molecularProfile": {
                "id": 18951,
                "profileName": "RIT1 Q79L"
            },
            "therapy": {
                "id": 3024,
                "therapyName": "Pictilisib + Selumetinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4469,
                    "pubMedId": 24469055,
                    "title": "Oncogenic RIT1 mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24469055"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4746,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Pictilisib (GDC-0941) inhibited transformation of cells expressing RIT1 Q79L in culture (PMID: 24469055).",
            "molecularProfile": {
                "id": 18951,
                "profileName": "RIT1 Q79L"
            },
            "therapy": {
                "id": 749,
                "therapyName": "Pictilisib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4469,
                    "pubMedId": 24469055,
                    "title": "Oncogenic RIT1 mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24469055"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18951,
            "profileName": "RIT1 Q79L",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 161621,
            "transcript": "NM_006912",
            "gDna": "chr1:g.155904732T>A",
            "cDna": "c.236A>T",
            "protein": "p.Q79L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}